The historical rank and industry rank for Ipca Laboratories's OCF Margin % or its related term are showing as below:
NSE:IPCALAB'
s OCF Margin % Range Over the Past 10 Years
Min: 9.11 Med: 12.75 Max: 20.32
Current: 11.84
During the past 13 years, the highest OCF Margin % of Ipca Laboratories was 20.32%. The lowest was 9.11%. And the median was 12.75%.
NSE:IPCALAB's OCF Margin % is ranked better than 57.14% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs NSE:IPCALAB: 11.84
Ipca Laboratories OCF Margin % Related Terms
Ipca Laboratories OCF Margin % Historical Data
* Premium members only.
The historical data trend for Ipca Laboratories's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ipca Laboratories OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Ipca Laboratories's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipca Laboratories (NSE:IPCALAB) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ipca Laboratories and its competitors. Over the past decade, Ipca Laboratories' OCF Margin % has ranged from 9.11 to 20.32. According to the industry distribution chart, Ipca Laboratories ranks #411 out of 959 companies in the Drug Manufacturers industry, placing it in the top 42.9%.
Is Ipca Laboratories' OCF Margin % too high?
Ipca Laboratories' current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 9.11 to a high of 20.32. Based on the distribution chart, Ipca Laboratories ranks #411 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ipca Laboratories has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ipca Laboratories' OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ipca Laboratories ranks #411 out of 959 companies for OCF Margin %. This puts Ipca Laboratories in the upper half of its industry. The industry median OCF Margin % is 9.94. Historically, Ipca Laboratories' own OCF Margin % has ranged from 9.11 to 20.32 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ipca Laboratories and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ipca Laboratories's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipca Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ipca Laboratories (NSE:IPCALAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,594.77, compared to a current price of ₹1,618.30 — trading 1.5% above its estimated fair value. The current OCF Margin % is 0.00%. Ipca Laboratories' overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Ipca Laboratories (NSE:IPCALAB), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ipca Laboratories (NSE:IPCALAB) Overvalued in 2026?
Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued.
The current stock price of ₹1,618.30 is trading 1.5% above its estimated GF Value™ of ₹1,594.77.
GuruFocus considers Ipca Laboratories to be Fairly Valued.
Key valuation signals for NSE:IPCALAB:
OCF Margin %: 0.00%
GF Value™: ₹1,594.77 vs. price of ₹1,618.30 (1.5% above fair value)
No single metric tells the full story. See the NSE:IPCALAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
86GF Score
Get the complete analysis for NSE:IPCALAB
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IPCALAB has been successfully added to your 
